Cleveland-Cliffs Inc
XETRA:CVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cleveland-Cliffs Inc
XETRA:CVA
|
US |
|
R
|
RattanIndia Power Ltd
BSE:533122
|
IN |
|
Orchid Pharma Ltd
NSE:ORCHPHARMA
|
IN |
|
Silvercrest Asset Management Group Inc
NASDAQ:SAMG
|
US |
|
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
ZA |
|
Asia Vital Components Co Ltd
TWSE:3017
|
TW |
|
Brookdale Senior Living Inc
NYSE:BKD
|
US |
|
A
|
Amazon.com Inc
XETRA:AMZ
|
US |
|
Cikarang Listrindo Tbk PT
IDX:POWR
|
ID |
Wall St Price Targets
CVA Price Targets Summary
Cleveland-Cliffs Inc
According to Wall Street analysts, the average 1-year price target for
CVA is 63.86 EUR with a low forecast of 44.86 EUR and a high forecast of 87.44 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CVA's stock price target?
Price Target
63.86
EUR
According to Wall Street analysts, the average 1-year price target for
CVA is 63.86 EUR with a low forecast of 44.86 EUR and a high forecast of 87.44 EUR.
What is the Revenue forecast for Cleveland-Cliffs Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 5%.